Objective explainers of major policy debates — issues and pending legislation.
Executive removal authority over independent agencies refers to the contested constitutional question of whether the President of the United States may dismiss commissioners and members of multi-member independent regulatory agencies—such as the FTC, SEC, FCC, NLRB, and EEOC—at will, or whether Congress may lawfully restrict such removals to instances of 'inefficiency, neglect of duty, or malfeasance in office.' The debate centers on how Article II of the Constitution, which vests executive power in the President, interacts with Congress's authority to design agencies insulated from direct presidential control.
Federal Reserve leadership and monetary policy direction refers to the selection of the Fed's chair and governors, their approach to setting interest rates and managing the central bank's balance sheet, and the degree to which the Fed operates free from executive and legislative pressure in pursuit of its dual congressional mandate of price stability and maximum employment.
Drug pricing policy encompasses the legislative, regulatory, and market-based mechanisms by which the United States sets, negotiates, or constrains the prices that consumers, insurers, and government programs pay for prescription medications. It is a long-running policy area involving federal negotiating authority, patent protections, pharmacy benefit manager (PBM) oversight, and the balance between drug affordability and pharmaceutical innovation.
The House-passed FISA Section 702 Reauthorization bill (approved 235–191 on April 29, 2026) extends for three years the authority of U.S. intelligence agencies to collect electronic communications of non-U.S. persons located abroad without an individual court order, while adding incremental oversight measures but stopping short of a warrant requirement before searching incidentally collected Americans' data.
Health Insurance & ACA encompasses the regulatory and subsidy architecture governing how Americans obtain health coverage — through ACA marketplaces, employer-sponsored plans, Medicaid, and Medicare — as well as ongoing policy debates over premium affordability, insurance market rules, pharmacy benefit manager (PBM) practices, and the role of government in subsidizing and regulating private insurance.
Climate and energy policy encompasses the laws, regulations, and public investments that govern how the United States produces and consumes energy, manages greenhouse gas emissions, and responds to climate change. Central debates involve the pace of transition away from fossil fuels, the future of clean-energy tax incentives, federal land leasing for oil and gas, electric vehicle adoption, and the role of nuclear power.
Immigration policy refers to the laws, regulations, and executive actions governing who may enter, remain in, and become a citizen of the United States, including rules for legal admission, asylum and refugee protection, enforcement against unauthorized presence, and pathways to permanent residency or citizenship.